MYOS RENS Technology Stock Price

0.01 (0.73%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
MYOS RENS Technology Inc MYOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.01 0.74% 1.37 1.32 1.39 1.34 1.36 00:00:03
Bid Price Ask Price Spread Spread % News
1.32 1.44 0.12 8.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
977 290,205 $ 1.36 $ 394,153 8,194,198 0.70 - 3.85
Last Trade Time Type Quantity Stock Price Currency
18:54:07 formt 100 $ 1.38 USD

MYOS RENS Technology Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 16.23M 11.85M 5.89M $ 1.03M $ - -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 208.27k 68.00%

more financials information »

MYOS RENS Technology News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.551.771.271.431,806,052-0.18-11.61%
1 Month0.933.850.862.4212,633,7060.4447.31%
3 Months1.143.850.83952.274,622,7300.2320.18%
6 Months1.313.850.702.262,134,9600.064.58%
1 Year1.623.850.702.261,051,745-0.25-15.43%
3 Years1.903.850.702.08478,042-0.53-27.89%
5 Years3.29997.000.702.54380,670-1.93-58.48%

MYOS RENS Technology Description

Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 03:28:57